Published in Women's Health Weekly, June 20th, 2002
Osteoporosis is a degenerative bone disease estimated to affect one-third of women ages 60 to 70, and two-thirds of women ages 80 or older. Current treatments primarily halt loss of bone density, but do not reverse the effects of osteoporosis. Through extensive genetic research carried out at its Seattle research center, Celltech has identified a protein involved in the regulation of bone deposition. It is believed that by inhibiting this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.